BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Morgan Stanley upgrades Dr. Reddy's Laboratories to overweight
The brokerage says Dr. Reddy's US pipeline outlook has strengthened and valuation appears to be reasonable.FY16 and FY17 are going to better as underlined by improving India and US business, it added.